title: Increase of meningococcal serogroup Y cases in Europe: a reason for concern?
abstract: Neisseria meningitidis is differentiated into 12 distinct serogroups of which A, B, C, W-135, X and Y are medically most important and represent a major health problem in one or more parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. A sudden increase or decrease of IMD or meningococcal carriage may occur anywhere at any time. Recent epidemiological surveillance indicates an increase of serogroup Y IMD in some parts of Europe and data from various European countries are presented.
authors.affiliation: Novartis Vaccines and Diagnostics GmbH, Scientific Affairs, Emil von Behring-Str. 76, Marburg, Germany 35041, Germany. Michael.Broeker@Novartis.com
authors.forename: Michael
authors.initials: M
authors.lastname: Bröker
authors.forename: Susanne
authors.initials: S
authors.lastname: Jacobsson
authors.forename: Lisa
authors.initials: L
authors.lastname: DeTora
authors.forename: David
authors.initials: D
authors.lastname: Pace
authors.forename: Muhamed-Kheir
authors.initials: MK
authors.lastname: Taha
mesh_terms: D005060:Europe / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008589:Meningococcal Infections / Q000453:epidemiology* / Q000382:microbiology*; D038581:Neisseria meningitidis, Serogroup Y / Q000302:isolation & purification*; D015995:Prevalence